Hair loss is considered widespread in recent years and has many degrees, as it begins with hair loss and may eventually lead to complete hair loss. There are many causes, the most important of which ...

The researchers found that COVID-19 was significantly associated with an increased risk for alopecia areata, alopecia totalis, vitiligo, Behçet disease, Crohn disease, ulcerative colitis, rheumatoid ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

The growing demand for alopecia treatments is mainly driven by the rising global prevalence of alopecia, influenced by ...

Pediatric alopecia areata prevalence is higher among Hispanic, Asian/Pacific Islander, and Black children compared with non-Hispanic White children. South Asian, Filipino, and Vietnamese children ...

Alopecia areata and asthma share inflammatory pathways, with IL-33 playing a significant mediating role in their association. Mendelian randomization analysis revealed a strong link between asthma ...

In some cases, alopecia areata can turn into alopecia totalis, when hair loss can spread across the entire head, or alopecia universalis when it affects the entire body. There is currently no cure ...

Treatment with ritlecitinib sustained hair regrowth through week 48 in patients with alopecia areata (AA), and up to one third of nonresponders at week 24 also achieved responses by week 48.

The involvement can be so widespread as to involve the entire scalp (alopecia totalis) or entire body (alopecia universalis). While the hair loss of AA itself is not usually symptomatic ...